Invitrogen to Acquire BioReliance in $500 Million Deal

genomeweb
360dx

Invitrogen to Acquire BioReliance in $500 Million Deal

Dec 26, 2003

NEW YORK, Dec. 26 (GenomeWeb News) -- Carlsbad, Calif.-based Invitrogen announced Wednesday that it will acquire BioReliance, a contract service organization based in Rockville, Md., in a transaction valued at $500 million.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Genomics Medicine Ireland, Academic Collaborators to Study Asthma Genetics
European Cancer Charities Award $39.4M in Research Grants
Drugs Targeting Lipolysis Could Confer Additional Cardiovascular Benefit, Genetic Analysis Finds
Cepheid Fingerstick HCV Test Receives CE-IVD Clearance
Fleury Group to License IDbyDNA NGS Platform
Long Noncoding RNAs Classified Based on Sequence Motifs

The Scan

NIH's Collins on Harassment

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

With Eight Arms and Giant Eyes

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Missing From Trials

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

This Week in Cell

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.

Main menu